Newsroom

  • Category

  • By Date

  • Press Release

    10 July 23

    CuraTeQ Biologics to market Ustekinumab biosimilar to treat Crohn’s disease, arthritis

    Read more
  • Press Release

    05 July 23

    CuraTeQ Biologics announces positive Phase-3 results for Trastuzumab biosimilar

    Read more
  • Press Release

    12 January 22

    Aurobindo Pharma arm CuraTeQ expands scope of biosimilars distribution pact with Orion

    Aurobindo Pharma on Tuesday said its subsidiary CuraTeQ Biologics has expanded the scope…

    Read more